Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus

Int J Mol Sci. 2018 May 14;19(5):1459. doi: 10.3390/ijms19051459.

Abstract

Since the beginning of the epidemic, human immunodeficiency virus (HIV) has infected around 70 million people worldwide, most of whom reside is sub-Saharan Africa. There have been very promising developments in the treatment of HIV with anti-retroviral drug cocktails. However, drug resistance to anti-HIV drugs is emerging, and many people infected with HIV have adverse reactions or do not have ready access to currently available HIV chemotherapies. Thus, there is a need to discover new anti-HIV agents to supplement our current arsenal of anti-HIV drugs and to provide therapeutic options for populations with limited resources or access to currently efficacious chemotherapies. Plant-derived natural products continue to serve as a reservoir for the discovery of new medicines, including anti-HIV agents. This review presents a survey of plants that have shown anti-HIV activity, both in vitro and in vivo.

Keywords: acquired immune deficiency syndrome; antiviral; drug discovery; pharmacognosy; phytochemistry.

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / chemistry
  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use*
  • Biological Products / chemistry
  • Biological Products / pharmacology
  • Biological Products / therapeutic use
  • Clinical Trials as Topic
  • Drug Discovery
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • HIV-1 / drug effects*
  • HIV-1 / physiology
  • Humans
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use*
  • Plants, Medicinal / chemistry*
  • Plants, Medicinal / metabolism
  • Secondary Metabolism
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Biological Products
  • Plant Extracts